RxDoctor Payments Data

Stephen Pirotta, DPM

Podiatrist · Bentonville, ARNPI 1053311944

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,537 of the $4,498 with a category attached, or 78.6%. 23 manufacturers reported payments, led by Amgen at 37.5% of the total.

$4,498in general payments, 2019–2025

Across 208 payments — averaging $21.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$2K
  • Treace Medical Concepts, Inc.$1K
  • Paratek Pharmaceuticals, Inc.$458
  • Kowa Pharmaceuticals America, Inc.$255
  • Organogenesis Inc.$173
  • Melinta Therapeutics, LLC$83
  • plus $676 from 17 others

What the payments were for

  • Travel & lodging$93221%
  • Food & beverage$3,53779%
  • Education$291%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,498 in reported general payments places this provider in the 85th percentile of 35 podiatrist providers in Arkansas.

See all podiatrist providers in Arkansas

Medicare billing

Part B allowed, 2024
$234,685
Medicare patients
458
Services billed
1,879

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin130$2,112
Pregabalin80$1,801
Prednisone115$1,422
Ciclopirox38$1,318
Linezolid13$777
Terbinafine Hcl50$630
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav42$572
Diclofenac Sodium45$513
Cephalexin47$371
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen33$310
Meloxicam113$302
Duloxetine Hcl11$208
Clindamycin Hcl17$181
Ibuprofen24$171
Allopurinol24$143

Paid to pharmacies, not to this prescriber.

Other podiatrist in Bentonville

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →